tiprankstipranks
Advertisement
Advertisement

Takasago Profit Falls on Weaker U.S. Shipments and Delayed Fine Chemical Sales

Story Highlights
  • Takasago saw stable Japan flavor sales and solid China demand but delayed fine chemical shipments and ERP-related disruptions in Europe.
  • Fiscal 2025 net sales slipped 1.8% while operating profit fell 47% and net income dropped 28.5% on weaker U.S. business.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Takasago Profit Falls on Weaker U.S. Shipments and Delayed Fine Chemical Sales

Meet Samuel – Your Personal Investing Prophet

The latest update is out from Takasago International Corporation ( (JP:4914) ).

Takasago International Corporation reported largely stable domestic flavor sales and solid demand for beverage flavors and fabric-care fragrances in China during fiscal 2025, but faced higher raw material import costs in Japan due to yen depreciation. The company’s fine chemicals segment postponed overseas shipments of pharmaceutical intermediates while enhancing quality management with key clients, and its French operations saw lower fragrance shipments amid ERP-related delivery adjustments.

Consolidated net sales declined 1.8% year on year to ¥225.1 billion, as U.S. subsidiary shipments of flavors, fragrances, and fine chemicals fell after the prior year’s backlog clearance. Operating profit dropped 47.0% to ¥8.1 billion and ordinary profit fell 37.9% to ¥9.5 billion, driven mainly by reduced shipments from Japan headquarters to the U.S. subsidiary and weaker U.S. sales, although foreign exchange gains and a gain on sale of investment securities partly offset the profit decline, leaving net income attributable to owners down 28.5% at ¥9.5 billion.

More about Takasago International Corporation

Takasago International Corporation is a Japanese manufacturer in the flavors, fragrances, and fine chemicals industry. The company supplies flavorings for foods and beverages, fragrances for consumer products such as fabric care, and pharmaceutical intermediates, serving both domestic and overseas markets including China, the U.S., and Europe.

Average Trading Volume: 201,736

Technical Sentiment Signal: Hold

Current Market Cap: Yen122.2B

For a thorough assessment of 4914 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1